Summaries for patients. What is the most cost-effective way to protect people in the event of an anthrax terror attack?
D000881:Anthrax / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000009:adverse effects / Q000191:economics*; D019072:Antibiotic Prophylaxis / Q000191:economics*; D023482:Bioterrorism / Q000191:economics*; D002947:Cities; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D006801:Humans; D015233:Models, Statistical; D019057:Quality-Adjusted Life Years; D012680:Sensitivity and Specificity; D014481:United States; D014611:Vaccination / Q000009:adverse effects / Q000191:economics*
D022122:Anthrax Vaccines